Veeva OpenData Expands to Italy with the Acquisition of Merqurio's Healthcare Professional and Organisation Database

Jul 23, 2015, 01:03 ET from Veeva Systems

BARCELONA, Spain and NAPOLI, Italy, July 23, 2015 /PRNewswire/ --

Veeva OpenData customer reference data and services are now available in Italy - the third major European market following the UK and France

Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.

     (Logo: http://photos.prnewswire.com/prnh/20120425/527164 )

Veeva OpenData provides customer reference data and services to the life sciences industry and delivers millions of comprehensive HCP, HCO, and affiliations profiles with consistent standards of quality. In keeping with Veeva OpenData's aim to provide the highest-quality data, the newly acquired Merqurio database has earned ISO 10002:2013 SGCMF certification for its accordance with European and Italian law in the management, security, and compliance of personal data collected for physicians.

Veeva OpenData offers fair and simple pricing and does away with complex and restrictive three-party agreements that limit data usage and access. And to eliminate the burden of managing multiple data feeds and duplication of HCP and HCO records across European markets, Veeva OpenData is sourced locally and consolidated into a single reference database.

"We are pleased to now offer customer data and services for life sciences companies in the Italian market," said Francesca D'Angelo, vice president of Veeva OpenData Products for Europe. "We are bringing a customer-first approach to the European data market with reliable data and faster, more responsive service, and by freeing companies to fully utilise the data they purchase, without restrictions."

"Veeva OpenData is a breakthrough for the life sciences industry," said Salvatore Ruggiero, CEO of Merqurio. "Veeva's 'open' approach allows companies to use data where, when, and how they need it. And developing a global solution will provide consistent customer data across borders, which is critical to ensuring compliance in Europe."

Veeva and Merqurio will maintain an ongoing partnership for the Italian market, under which Merqurio can leverage Veeva OpenData for customer data as part of its multichannel marketing services. Merqurio clients will benefit from Veeva OpenData's complete HCP and HCO data, as well as OpenData's unique HCP identifier, so any multichannel activity Merqurio executes is tracked against the right HCP. The result is a complete and continuously updated customer view.

To best support customer needs globally, Veeva OpenData is being developed for all of the life sciences' major markets, and is available today in Australia, China, France, Italy, the UK, and the US. Availability in other major Western European countries and Japan is expected in 2015, with additional major countries to follow in 2016.

Additional Information 

About Veeva OpenData 

Central to the Veeva OpenData data and services offerings is Veeva OpenData Customer Data, which includes records for millions of HCPs, HCOs, and affiliations. Customer records are continuously updated from authoritative industry sources for the best, most timely information. The highest standards of quality and completeness are ensured through rigorous, automated, and steward-led validation. Veeva also provides a range of data maintenance services, including cleansing, enhancement, and validation.

To help the industry realise greater value from customer data, a large and growing contingent of organisations have already become Veeva OpenData partners, including Alanda, Axtria, BMI SYSTEM, Crossix Solutions, Decision Resources Group, HighPoint Solutions, LiquidHub, MediSpend, Medpages, OpenQ, Pharma Advisor, Qlik, Symphony Health Solutions, Technekes, Zephyr Health, and ZS Associates.

About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 275 customers ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit http://www.veeva.com.

About Merqurio Group  

Merqurio Group offers services to life sciences companies in the areas of scientific information (CSO), e-detailing, and phone detailing. Merqurio is a highly innovative company and a member of the pharmaceutical association Farmindustria. It counts a number of certifications, including the SGCMF, 27001. With over 150 employees, Merqurio is a €15 million revenue company. For more information, visit http://www.merqurio.it.

Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of the Veeva OpenData products and related services, the results from use of the Veeva OpenData products and related services, the benefits of Veeva's partnership with Merqurio and other third parties, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva's historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva's expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva's financial results are included under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's filing on Form 10-Q for the period ended April 30, 2015. This is available on the company's website at http://www.veeva.com under the Investors section and on the SEC's website at http://www.sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

Contact:

Sue Glanville / Cate Bonthuys
Veeva Systems Inc.
sue@catalystcomms.co.uk / cate@catalystcomms.co.uk

Alfonso Moscato
Merqurio Group
alfonso.moscato@merqurio.it

SOURCE Veeva Systems